Heon-Woo Lee1, Yanying Xu1,2, Liqun He3, Woosoung Choi4, David Gonzalez5, Suk-Won Jin1,4, Michael Simons1,6. 1. Yale Cardiovascular Research Center (H.-W.L., Y.X., S.-W.J., M.S.), Yale University School of Medicine, New Haven, CT. 2. Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China (Y.X.). 3. Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Sweden (L.H.). 4. School of Life Sciences and Cell Logistics Research Center, Gwangju Institute of Science and Technology, Korea (W.C., S.-W.J.). 5. Department of Genetics (D.G.), Yale University School of Medicine, New Haven, CT. 6. Department of Cell Biology (M.S.), Yale University School of Medicine, New Haven, CT.
Abstract
BACKGROUND: Angiogenesis is a dynamic process that involves expansion of a preexisting vascular network that can occur in a number of physiological and pathological settings. Despite its importance, the origin of the new angiogenic vasculature is poorly defined. In particular, the primary subtype of endothelial cells (capillary, venous, arterial) driving this process remains undefined. METHODS: Endothelial cells were fate-mapped with the use of genetic markers specific to arterial and capillary cells. In addition, we identified a novel venous endothelial marker gene (Gm5127) and used it to generate inducible venous endothelium-specific Cre and Dre driver mouse lines. Contributions of these various types of endothelial cells to angiogenesis were examined during normal postnatal development and in disease-specific setting. RESULTS: Using a comprehensive set of endothelial subtype-specific inducible reporter mice, including tip, arterial, and venous endothelial reporter lines, we showed that venous endothelial cells are the primary endothelial subtype responsible for the expansion of an angiogenic vascular network. During physiological angiogenesis, venous endothelial cells proliferate, migrating against the blood flow and differentiating into tip, capillary, and arterial endothelial cells of the new vasculature. Using intravital 2-photon imaging, we observed venous endothelial cells migrating against the blood flow to form new blood vessels. Venous endothelial cell migration also plays a key role in pathological angiogenesis. This was observed both in formation of arteriovenous malformations in mice with inducible endothelium-specific Smad4 deletion mice and in pathological vessel growth seen in oxygen-induced retinopathy. CONCLUSIONS: Our studies establish that venous endothelial cells are the primary endothelial subtype responsible for normal expansion of vascular networks, formation of arteriovenous malformations, and pathological angiogenesis. These observations highlight the central role of the venous endothelium in normal development and disease pathogenesis.
BACKGROUND: Angiogenesis is a dynamic process that involves expansion of a preexisting vascular network that can occur in a number of physiological and pathological settings. Despite its importance, the origin of the new angiogenic vasculature is poorly defined. In particular, the primary subtype of endothelial cells (capillary, venous, arterial) driving this process remains undefined. METHODS: Endothelial cells were fate-mapped with the use of genetic markers specific to arterial and capillary cells. In addition, we identified a novel venous endothelial marker gene (Gm5127) and used it to generate inducible venous endothelium-specific Cre and Dre driver mouse lines. Contributions of these various types of endothelial cells to angiogenesis were examined during normal postnatal development and in disease-specific setting. RESULTS: Using a comprehensive set of endothelial subtype-specific inducible reporter mice, including tip, arterial, and venous endothelial reporter lines, we showed that venous endothelial cells are the primary endothelial subtype responsible for the expansion of an angiogenic vascular network. During physiological angiogenesis, venous endothelial cells proliferate, migrating against the blood flow and differentiating into tip, capillary, and arterial endothelial cells of the new vasculature. Using intravital 2-photon imaging, we observed venous endothelial cells migrating against the blood flow to form new blood vessels. Venous endothelial cell migration also plays a key role in pathological angiogenesis. This was observed both in formation of arteriovenous malformations in mice with inducible endothelium-specific Smad4 deletion mice and in pathological vessel growth seen in oxygen-induced retinopathy. CONCLUSIONS: Our studies establish that venous endothelial cells are the primary endothelial subtype responsible for normal expansion of vascular networks, formation of arteriovenous malformations, and pathological angiogenesis. These observations highlight the central role of the venous endothelium in normal development and disease pathogenesis.
Authors: Aruna Poduri; Andrew H Chang; Brian Raftrey; Siyeon Rhee; Mike Van; Kristy Red-Horse Journal: Development Date: 2017-07-31 Impact factor: 6.868
Authors: Joanna Kalucka; Laura P M H de Rooij; Jermaine Goveia; Katerina Rohlenova; Sébastien J Dumas; Elda Meta; Nadine V Conchinha; Federico Taverna; Laure-Anne Teuwen; Koen Veys; Melissa García-Caballero; Shawez Khan; Vincent Geldhof; Liliana Sokol; Rongyuan Chen; Lucas Treps; Mila Borri; Pauline de Zeeuw; Charlotte Dubois; Tobias K Karakach; Kim D Falkenberg; Magdalena Parys; Xiangke Yin; Stefan Vinckier; Yuxiang Du; Robert A Fenton; Luc Schoonjans; Mieke Dewerchin; Guy Eelen; Bernard Thienpont; Lin Lin; Lars Bolund; Xuri Li; Yonglun Luo; Peter Carmeliet Journal: Cell Date: 2020-02-13 Impact factor: 41.582
Authors: Jermaine Goveia; Katerina Rohlenova; Federico Taverna; Lucas Treps; Lena-Christin Conradi; Andreas Pircher; Vincent Geldhof; Laura P M H de Rooij; Joanna Kalucka; Liliana Sokol; Melissa García-Caballero; Yingfeng Zheng; Junbin Qian; Laure-Anne Teuwen; Shawez Khan; Bram Boeckx; Els Wauters; Herbert Decaluwé; Paul De Leyn; Johan Vansteenkiste; Birgit Weynand; Xavier Sagaert; Erik Verbeken; Albert Wolthuis; Baki Topal; Wouter Everaerts; Hanibal Bohnenberger; Alexander Emmert; Dena Panovska; Frederik De Smet; Frank J T Staal; Rene J Mclaughlin; Francis Impens; Vincenzo Lagani; Stefan Vinckier; Massimiliano Mazzone; Luc Schoonjans; Mieke Dewerchin; Guy Eelen; Tobias K Karakach; Huanming Yang; Jian Wang; Lars Bolund; Lin Lin; Bernard Thienpont; Xuri Li; Diether Lambrechts; Yonglun Luo; Peter Carmeliet Journal: Cancer Cell Date: 2020-01-13 Impact factor: 31.743
Authors: Dorothea Reimer; Michael Meyer-Hermann; Asylkhan Rakhymzhan; Tobit Steinmetz; Philipp Tripal; Jana Thomas; Martin Boettcher; Dimitrios Mougiakakos; Sebastian R Schulz; Sophia Urbanczyk; Anja E Hauser; Raluca A Niesner; Dirk Mielenz Journal: Cell Rep Date: 2020-08-11 Impact factor: 9.423
Authors: Kerstin Wilhelm; Alexandre Dubrac; Joe K Tung; Pengchun Yu; Tiago C Alves; Jennifer S Fang; Yi Xie; Jie Zhu; Zehua Chen; Frederik De Smet; Jiasheng Zhang; Suk-Won Jin; Lele Sun; Hongye Sun; Richard G Kibbey; Karen K Hirschi; Nissim Hay; Peter Carmeliet; Thomas W Chittenden; Anne Eichmann; Michael Potente; Michael Simons Journal: Nature Date: 2017-05-03 Impact factor: 49.962